Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- And High-Risk Prostate Cancer Across the United States

JAMA Oncology - United States
doi 10.1001/jamaoncol.2016.1143
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Combined Brachytherapy and External Beam Radiotherapy Without Adjuvant Androgen Deprivation Therapy for High-Risk Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Is Neoadjuvant Androgen Deprivation Therapy Necessary for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Benefit of Whole Pelvic Radiotherapy Combined With Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer

Journal of Biomedicine and Biotechnology
2009English

Androgen Deprivation Therapy for Prostate Cancer

2017English

Three-Month Posttreatment Prostate-Specific Antigen Level as a Biomarker of Treatment Response in Patients With Intermediate-Risk or High-Risk Prostate Cancer Treated With Androgen Deprivation Therapy and Radiotherapy

Cancer
Cancer ResearchOncology
2018English

The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Evaluation of the Effectiveness of Adding Androgen Deprivation to Modern Dose-Escalated Radiotherapy for Men With Favorable Intermediate-Risk Prostate Cancer

Cancer
Cancer ResearchOncology
2016English

High-Dose Radiation Employing External Beam Radiotherapy and High-Dose Rate Brachytherapy With and Without Neoadjuvant Androgen Deprivation for Prostate Cancer Patients With Intermediate- And High-Risk Features

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy